In particular, WNT/TGF‐β signalling pathway was activated in CAFs‐immune subtype; TGF‐β regulates tumour‐stroma interactions, EMT, angiogenesis and metastasis and can suppress the host anti‐tumour immune response, leading to a poor prognosis. Here, TGFB1 is linked to neoplasm.